Biovailability and dosing-schedules of 7-monohydroxy-ethylrutoside, a protector against doxorubicin-induced cardiotoxicity.

F.A.A. van Acker, M.A. Abulhassan, S.A.B.E. van Acker, G.R.M.M. Haenen, A. Bast, W.J.F. van der Vijgh, K. Kramer

Research output: Contribution to JournalArticleAcademic

Original languageEnglish
JournalAnnual Meeting of the American Association for Cancer Research. Proceedings
Issue number10
Publication statusPublished - 1999

Cite this